HYDERABAD, India, Nov. 28, 2025 /PRNewswire/ -- Bhanzu, the fastest-growing global math learning platform has launched its first-ever physical learning…
Ghent, Belgium, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Milestone in bringing breakthrough treatment option to US patients with recurrent and…
Grant Proceeds Will Accelerate Research and Commercialization of Electrochemical Manufacturing of High-Performance GraphiteDALLAS, Nov. 21, 2025 /PRNewswire/ -- Solidion Technology…
NEW YORK, Nov. 21, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from…
WASHINGTON, Nov. 17, 2025 /PRNewswire/ -- Today, the Open Doors® 2025 Report on International Educational Exchange, the leading annual benchmark for…
BEIJING, Nov. 14, 2025 /PRNewswire/ -- Token Cat Limited (Nasdaq: TC) today announced that, after divesting its long-term unprofitable business and…
INSIDE INFORMATIONREGULATED INFORMATION Correction and ReplacementNyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of…
TAMPA, Fla., Nov. 11, 2025 /PRNewswire/ -- Veterans Day – The Office of the Assistant Secretary of War (OASW) for…
HONG KONG, Nov. 10, 2025 (GLOBE NEWSWIRE) -- NUNA pendant arrives at the beginning of the holiday gift season, a…
Atacicept received FDA Breakthrough Therapy Designation for the treatment of IgANORIGIN Phase 3 trial met its primary endpoint at the…